Evidence map›Paper›PMID 29343461›Full record

ArticleJMIR research protocols2018

Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study.

Ruth Ann Marrie, Lesley Graff, John R Walker, John D Fisk, Scott B Patten, Carol A Hitchon, Lisa M Lix, James Bolton, Jitender Sareen, Alan Katz and 7 more

Open access · goldAbstract read
In one paragraph

Article in JMIR research protocols, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 3 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 3 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Ruth Ann MarrieUniversity of Manitoba, Winnipeg, MB, Canada.ORCID http://orcid.org/0000-0002-1855-5595
Lesley GraffUniversity of Manitoba, Winnipeg, MB, Canada.ORCID http://orcid.org/0000-0002-0743-3189
John R WalkerUniversity of Manitoba, Winnipeg, MB, Canada.ORCID http://orcid.org/0000-0002-5349-1689
John D FiskDalhousie University, Winnipeg, MB, Canada.ORCID http://orcid.org/0000-0003-3512-8015
Scott B PattenUniversity of Calgary, Calgary, AB, Canada.ORCID http://orcid.org/0000-0001-9871-4041
Carol A HitchonUniversity of Manitoba, Winnipeg, MB, Canada.ORCID http://orcid.org/0000-0001-5547-3268
Lisa M LixUniversity of Manitoba, Winnipeg, MB, Canada.ORCID http://orcid.org/0000-0001-8685-3212
James BoltonUniversity of Manitoba, Winnipeg, MB, Canada.ORCID http://orcid.org/0000-0001-6319-5181
Jitender SareenUniversity of Manitoba, Winnipeg, MB, Canada.ORCID http://orcid.org/0000-0001-8573-6495
Alan KatzUniversity of Manitoba, Winnipeg, MB, Canada.ORCID http://orcid.org/0000-0001-8280-7024
Lindsay I BerriganSt. Francis Xavier University, Antigonish, NS, Canada.ORCID http://orcid.org/0000-0002-1359-8967
James J MarriottUniversity of Manitoba, Winnipeg, MB, Canada.ORCID http://orcid.org/0000-0001-5491-0569
Alexander SingerUniversity of Manitoba, Winnipeg, MB, Canada.ORCID http://orcid.org/0000-0001-5436-8394
Renée El-GabalawyUniversity of Manitoba, Winnipeg, MB, Canada.ORCID http://orcid.org/0000-0002-3445-5607
Christine A PeschkenUniversity of Manitoba, Winnipeg, MB, Canada.ORCID http://orcid.org/0000-0002-4269-5213
Ryan ZarychanskiUniversity of Manitoba, Winnipeg, MB, Canada.ORCID http://orcid.org/0000-0001-9455-6138
Charles N BernsteinUniversity of Manitoba, Winnipeg, MB, Canada.ORCID http://orcid.org/0000-0001-8041-3574
University of Manitoba · CADalhousie University · CASt. Francis Xavier University · CAUniversity of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImmune-mediated inflammatory diseases (IMID), such as inflammatory bowel disease (IBD), multiple sclerosis (MS), and rheumatoid arthritis (RA), are highly prevalent in Canada and the United States and result in substantial personal and societal burden. The prevalence of psychiatric comorbidities, primarily depression and anxiety, in IMID exceeds those in the general population by two- to threefold, but remains underdiagnosed and undertreated. Furthermore, the effects of psychiatric comorbidity on IMID are not well understood.

objectiveThe objectives of this study were (1) to compare health-related quality of life and work ability in persons with IMID and psychiatric comorbidity with those of persons with IMID without psychiatric comorbidity and with those of persons with depression and anxiety disorders alone, and (2) to validate existing case identification tools for depression and anxiety in persons with IMID to facilitate improved identification of depression and anxiety by clinicians. To achieve these objectives, we designed a prospective 3-year longitudinal study. In this paper, we aim to describe the study rationale and design and the characteristics of study participants.

methodsBetween November 2014 and July 2016, we recruited 982 individuals from multiple clinic and community sources; 18 were withdrawn due to protocol violations.

resultsThe final study sample included 247 participants with IBD, 255 with MS, 154 with RA, and 308 with depression or anxiety. The majority were white, with the proportion ranging from 85.4% (IBD [210/246]; MS [217/254]) to 74.5% (114/153, RA; P=.01). There was a female predominance in all groups, which was highest in the RA cohort (84.4%, 130/154) and least marked in the IBD cohort (62.7%, 155/247). Participants with depression or anxiety were more likely to be single (36.0%, 111/308) than participants in any other group (11.8% [30/255]-22.7% [56/247], P<.001).

conclusionsThis paper presents the rationale for this study, describes study procedures, and characterizes the cohort enrolled. Ultimately, the aim is improved care for individuals affected by IMID.

Indexed as

anxietydepressionepidemiologyinflammatory bowel diseasemultiple sclerosisrheumatoid arthritis

Identifiers

PMID29343461
PMCPMC5792704
OpenAlexW2783460893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.